相关实验视频

Updated: Jul 15, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

癌症免疫治疗的试验设计:一种方法论工具包

Everardo D Saad¹, Elisabeth Coart¹, Vaiva Deltuvaite-Thomas¹

¹International Drug Development Institute, Louvain-la-Neuve (IDDI), 1340 Ottignies-Louvain-la-Neuve, Belgium.

|September 28, 2023

概括

检查点抑制剂 (CPI) 和基于细胞的疗法改变了癌症治疗,需要适应临床试验设计和免疫瘤药物开发的统计方法. 本综述探讨了这些创新疗法的早期和晚期试验考虑因素.

科学领域:

在瘤学瘤学.
临床试验临床试验
免疫治疗是一种免疫疗法.

背景情况:

免疫疗法,包括检查点抑制剂 (CPI) 和基于细胞的产品,已经显著推进了固体瘤和血液恶性瘤的癌症治疗.
这些药物的成功需要新的临床试验设计方法和药物开发中的疗效/安全性评估.

研究的目的:

讨论免疫瘤学早期和晚期临床试验设计中的关键问题,重点关注CPI.
突出传统统计方法的局限性,并提出免疫疗法药物开发的替代方法.

主要方法:

早期阶段试验中突出问题的审查:剂量升级,瘤反应标准,反应持续时间和早期随机化.
讨论晚期试验考虑因素:主要终点,代用终点和特定的统计挑战.
探索统计方法,包括考克斯模型的替代方案和免疫治疗的通用对对比.

主要成果:

传统的统计方法可能不太适合免疫瘤学,需要适应的方法.
早期试验应优先考虑剂量升级,适当的反应标准和早期随机化.
晚期试验需要仔细选择终点,考虑代用终点,以及先进的统计方法,以解决独特的免疫疗法特征.

结论:

调整临床试验设计和统计方法对于优化新型免疫疗法的开发至关重要.
以患者为中心的评估和创新的统计方法对于准确评估CPI和其他免疫治疗剂的有效性和安全性至关重要.

关键词:

检查点抑制剂检查点抑制剂免疫疗法免疫疗法试验设计试验设计.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...